✦ LIBER ✦

Adrenal tumors inBRCA1/BRCA2 mutation carriers

✍ Scribed by Barak, Frieda ;Shiri-Svredlov, Ronit ;Bruchim-Bar Sade, Revital ;Kruglikova, Anna ;Friedman, Eitan ;Ben-Dor, David ;Goldberg, Iris

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 59 KB
Volume: 98
Category: Article
ISSN: 0148-7299
DOI: 10.1002/1096-8628(20010122)98:3<277::aid-ajmg1082>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequent somatic mutations ofGATA3in non

Frequent somatic mutations ofGATA3in non-BRCA1/BRCA2familial breast tumors, but not inBRCA1-, BRCA2-or sporadic breast tumors

✍ Jeremy M. Arnold; David Y. H. Choong; Ella R. Thompson; kConFab; Nic Waddell; Ge 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 179 KB

Risk-reducing salpingo-oophorectomy inBR

Risk-reducing salpingo-oophorectomy inBRCA1andBRCA2mutation carriers

✍ Kerstin Rhiem; Dolores Foth; Barbara Wappenschmidt; Heidrun Gevensleben; Reinhar 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 219 KB

Chromosome 5 imbalance mapping in breast

Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors

✍ Hrefna K. Johannsdottir; Goran Jonsson; Gudrun Johannesdottir; Bjarni A. Agnarss 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 1015 KB

## Abstract Comparative genomic hybridization (CGH) analysis has shown that chromosome 5q deletions are the most frequent aberration in breast tumors from __BRCA1__ mutation carriers. To map the location of putative 5q tumor suppressor gene(s), 26 microsatellite markers covering chromosome 5 were u

Multiple copies of mutant BRCA1 and BRCA

Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers

✍ Synnöve Staff; Nina N. Nupponen; Åke Borg; Jorma J. Isola; Minna M. Tanner 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

BRCA1 and BRCA2 mutation carriers as pot

BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials

✍ Ephrat Levy-Lahad; Michal Krieger; Orit Gottfeld; Paul Renbaum; Gaya Klein; Shlo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

The identification of cancer susceptibility genes offers new avenues for selecting high-risk individuals as subjects for chemoprevention trials. Because carriers of predisposing mutations are at high risk, they are more likely to enroll and comply with chemoprevention trials, and meaningful results

Risk of ipsilateral breast cancer in BRC

Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers

✍ Kelly Metcalfe; Henry T. Lynch; Parviz Ghadirian; Nadine Tung; Charmaine Kim-Sin 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 195 KB